Login / Signup

Levothyroxine therapy, calculated deiodinases activity and basal metabolic rate in obese or nonobese patients after total thyroidectomy for differentiated thyroid cancer, results of a retrospective observational study.

Rosario Le MoliPasqualino MalandrinoMarco RussoDario TuminoTommaso PiticchioAdriano NaselliValentina RapicavoliAntonino BelfioreFrancesco Frasca
Published in: Endocrinology, diabetes & metabolism (2023)
L-t4 dose is the most important predictor of GD, BMR modulates T4 levels in obese athyreotic patients that are resistant to L-T4 replacement therapy.
Keyphrases
  • end stage renal disease
  • replacement therapy
  • ejection fraction
  • newly diagnosed
  • adipose tissue
  • metabolic syndrome
  • weight loss
  • prognostic factors
  • smoking cessation
  • mesenchymal stem cells